Cubist Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall Of One Lot Of CUBICIN (Daptomycin For Injection) 500 Mg In 10 Ml Single Use Vials Due To Presence Of Particulate Matter

Published: Apr 18, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICINĀ® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer.

Help employers find you! Check out all the jobs and post your resume.

Back to news